Abstract:The article examines the issue of public procurement in the healthcare sector through the prism of the Association Agreement with the EU. The emphasis is on the ensuring mutual access to the markets of public procurement of the EU and Ukraine on the basis of planned and consistent approximation of Ukrainian legislation in the field of public procurement to the EU acquis in the field of public procurement. The purpose of this article is to identify the peculiarities of the reform in the field of public procurement in Ukraine, to search for drawbacks in the administrative legislation of Ukraine, which is governing public procurement in the healthcare sector in the context of Ukraine's implementation of the Association Agreement with the EU, and to justify its improvement. The subject of research is the social relations that arise in the implementation of public procurement in the field of health. The methodological basis of the conducted research is the general methods of scientific cognitivism as well as concerning those used in legal science: methods of analysis and synthesis, formal logic, comparative law, statistical methods etc The following main directions of reforming the system of public procurement were established. It has been proved that CPO functioning on the national level of government in the form of a state-owned enterprise under the control of one of the relevant ministries is non-feasibility. The advantages of the ProZorro electronic procurement system and the state of implementation of the provisions of the EU Directives on 2014/23/ EU, 2014/24/ EU, 2014/25/EU, 2014/55/EU into the administrative legislation of Ukraine have been identified. It has been found that in March, 2015 centralized procurement system for medicines and medical products was changed in Ukraine to use the funds of the State Budget of Ukraine for the purchase of medicines and medical products with the involvement of international specialized organizations. On December 21, 2018 the Verkhovna Rada (Supreme Council) of Ukraine put amendments into the Law of Ukraine "On Public Procurement". The attention is paid to the novelties of this Law. It has been found that the legislation of Ukraine has such shortcomings: 1) in Ukraine the issue of clear distribution of functions of the authorities authorized to carry out control in the field of public procurements remains unresolved; 2) the norms of the Law contradict each other; 3) the problems of creating effective mechanisms for the formation of the nomenclature of medicines still remain, as well as their supplies to healthcare institutions.

Risks in the Drug Procurement System: Current Issues

Regulatory and legal regulation and monitoring of procurement of medicines and medical devices under a state of martial law

Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country

CORRUPTION RISKS IN LEGAL PROVISION OF PUBLIC PROCUREMENT FINANCING

EXPERIENCE IN IMPLEMENTING A SYSTEM OF MONITORING AND CENTRALIZED MANAGEMENT OF ANTITUMOR DRUGS PROCUREMENT BY MEDICAL ORGANIZATIONS IN THE SVERDLOVSK REGION

Building an internal communication mechanism for participants in the procurement process of a public health institution.

Tactical measures set to improve the import substitution process in the field of Russian pharmaceuticals

Public procurement in Russia: concept and content

PUBLIC PROCUREMENT IN THE HEALTHCARE SECTOR: ADAPTATION OF THE ADMINISTRATIVE LEGISLATION OF UKRAINE TO THE EU LEGISLATION

Public Procurement Efficiency as Perceived by Market Participants: The Case of Russia

Pharmaceutical industry in Russia: Key trends and developments

The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk

Current issues of import substitution in the procurement of medical institutions

[The pharmacy tourism. Part II. The prohibitions, limitations and risks at importation of medications by natural persons in the Russian Federation]

Current state and prospects for the development of the domestic pharmaceutical industry

Public procurement in construction: a critical review

MARKETING ANALYSIS OF RESILIENCE OF THE SUPPLY CHAIN OF THE RUSSIAN PHARMACEUTICAL INDUSTRY UNDER CONDITIONS OF EXTERNAL SHOCKS

[The characteristics of regulation of pharmaceutical market of the Eurasian Economical Union].

Analysis of changes in the pharmaceutical industry in Russia for 2020

DRUG POLICY IN GEORGIA AND ASPECTS OF PHARMACEUTICAL BUSINESS REGULATION

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS